Rad AI Announces Strategic Investments from Four Leading Health Systems to Advance Enterprise AI in Healthcare

SAN FRANCISCO, May 20, 2025 /PRNewswire/ -- Rad AI today announced an additional $8 million strategic investment to its latest funding round, led by four of the nation's most respected health systems — Advocate Health, Memorial Hermann Health System, Corewell Health, and Atlantic Health System. The additional investment brings Rad AI's total Series C funding to $68 million. These partnerships reflect a shared commitment to transform care delivery for millions of patients nationwide and to scale the use of generative AI across hospitals and clinics.

A Shared Commitment to Innovation and Scale

Advocate Health, Memorial Hermann Health System, Corewell Health, and Atlantic Health System are not just investors — they are partners shaping how generative AI is applied across complex clinical environments. Rad AI's success has always come from understanding and solving real clinical challenges with measurable impact. As the first generative AI company to achieve widespread adoption in radiology — and trusted by thousands of U.S. radiologists — Rad AI builds practical solutions that improve workflow, care quality, and patient outcomes. This partnership brings critical insight from leading health systems to accelerate the next wave of AI-driven innovation in healthcare.

"The impact of AI in healthcare is no longer theoretical — it's happening right now at scale," said Doktor Gurson, co-founder and CEO of Rad AI. "It's an honor to collaborate with these leading health systems to expand that impact even further, building solutions that improve care for millions of patients."

"Advocate Health's investment in AI solutions reflects our dedication to innovation and our belief that responsibly deployed AI tools can improve the lives of both our health care providers and our patients," said Andy Crowder, Chief Digital and AI Officer at Advocate Health. "By integrating AI solutions directly into our radiologists' workflows across our enterprise, while maintaining radiologist oversight, we expect to realize improved reporting efficiency, accuracy and quality, all while reducing burnout for our radiologists."

This announcement extends Rad AI's $60 million Series C financing round and marks a significant step forward in bringing AI innovation to healthcare providers. Collectively, these organizations operate over 100 hospitals and serve millions of patients across the U.S. Their partnership with Rad AI is already enabling system-wide adoption of advanced radiology and follow-up solutions — accelerating progress in areas where health systems face the greatest clinical and operational pressure.

Rad AI is one of the few AI companies solving end-to-end challenges for health systems—streamlining workflows and ensuring patients receive timely follow-up care. Its solutions support providers responsible for nearly half of all imaging volume in the U.S., helping radiologists work faster, reduce dictation load, and improve care quality.

"Memorial Hermann invests in AI not just to adapt to technology, but to transform patient care and improve workflows," said Feby Abraham, PhD, executive vice president and chief strategy officer for Memorial Hermann. "We are always seeking partners who can deliver measurable impact on outcomes, efficiency and improving the patient experience and Rad AI checks all those boxes."

Rather than offering standalone tools, Rad AI delivers an integrated solution to multifaceted clinical challenges:

• Rad AI Impressions — the first generative AI application widely adopted in radiology — automates the impression section of reports, saving radiologists more than an hour per shift on average so they can focus their time where it matters most.
• Rad AI Reporting enhances the full radiology workflow with features like Omni Unchanged, which pulls stable findings from prior reports with one phrase and cuts follow-up dictation time by 50% and spoken words by 90%. Omni Report enables radiologists to dictate naturally and auto-fills structured templates, up to doubling reporting speed and easing cognitive load.
• Rad AI Continuity closes the loop on incidental findings by automatically tracking and coordinating follow-up care. Health systems using Continuity have improved follow-up exam completion rates from approximately 30% to over 75%, helping ensure critical findings don't fall through the cracks.

Together, these tools enable a seamless path from diagnosis to action—supporting clinicians in delivering timely and coordinated care.

Millions of patients stand to benefit as Rad AI's platform scales — through faster reporting, coordinated follow-up, and reduced delays in care. These health systems are accelerating that impact by embedding AI into core workflows, not as a future vision but as a present-day priority.

"We are pleased to invest in a company that is at the forefront of developing technology to make the jobs of physicians more convenient and efficient," said Christian Rische, vice president and managing director, Corewell Health Ventures. "The products of Rad AI will help lead to a reduced workload for providers and, most importantly, potential improvements in patient care."

Building on Momentum

This investment from some of the most innovative and well-known health systems represents strong alignment with Rad AI's role as a trusted AI partner. It builds on Rad AI's momentum as the category-defining leader in generative AI for healthcare — trusted by many of the nation's largest health systems and recognized by Deloitte, CB Insights, AuntMinnie, and Accenture.

"The Atlantic Venture Studio, part of Atlantic Health System, is committed to investing in and supporting solutions to health care's biggest challenges," said Doug Hayes, Executive Director, Atlantic Venture Studio. "Our investment in AI applications like Rad AI are focused on transforming care by reducing the burden on physicians, improving the quality of care and building healthier communities."

About Rad AI

Rad AI is an industry leader in generative AI solutions for radiology, transforming the way radiologists work and improving patient care. The company's flagship product, Rad AI Reporting, streamlines radiology reporting with AI-driven technology and empowers radiologists to achieve greater efficiency, accuracy, and satisfaction. Rad AI Impressions, the company's pioneering product, established Rad AI as an innovator in generative AI for radiology; as the first generative AI application to achieve widespread adoption in radiology, it is now trusted by thousands of US radiologists. Rad AI Continuity, the most comprehensive solution of its kind, uses AI to help ensure patient follow-up for potential new cancers.

The company has been recognized as one of the most promising healthcare AI companies by CB Insights (Digital Health 50, AI 100) and AuntMinnie (Best New Radiology Software 2023, Best New Radiology Vendor 2021). In November of 2024, Rad AI was named the 19th fastest-growing company in North America on the Deloitte Fast 500.

Learn more about Rad AI at www.radai.com or on LinkedIn at www.linkedin.com/company/radai/

PR Contact: Wei Ting Hsieh, Rad AI, +1 ‪(302) 387-3622, [email protected]

SOURCE Rad AI